Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01905657
Brief Title: Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

First Submitted : July 18, 2013
First Submitted that Met QC Criteria : July 18, 2013
First Posted : July 23, 2013 (Estimate)

Results First Submitted : September 15, 2016
Results First Submitted that Met QC Criteria : November 23, 2016
Results First Posted : January 18, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : January 30, 2019
Last Update Posted : February 15, 2019